Accessibility Menu

STAAR Surgical(FRA) SR3

Market Cap€978.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€18.99
-0.81%
-0.16Today

STAAR Surgical Financials at a Glance

Market Cap

€978.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€291.11

Net Income (TTM)

€3.25

EPS (TTM)

€0.06

P/E Ratio

347.24

Dividend

€0.00

Beta (Volatility)

-0.03 (Low)

Price

€18.99

Volume

0

Open

€18.99

Previous Close

€18.99

Daily Range

€18.99 - €18.99

52-Week Range

€13.51 - €29.00

Estimated Earnings Date

N/A

SR3 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About STAAR Surgical

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Industry

Healthcare Equipment and Supplies

Employees

957

CEO

Deborah J. Andrews; Warren Foust, MBA

SR3 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

107.27%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

0.29%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€978.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

50.14M

Volume

0

Avg. Volume

22.727

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

STAAR Surgical Performance Analysis

STAAR Surgical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 270,597,47838.8%
20232023-12-31EUR 298,224,35210.2%
20242024-12-31EUR 290,194,770-2.7%
20252025-12-31EUR 212,162,571-26.9%
STAAR Surgical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.7682.4%
20232023-12-31EUR 0.40-47.7%
20242024-12-31EUR -0.38N/A
20252025-12-31EUR -1.44278.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€80.45

+2.1%

Gross Profit

€57.90

+2.1%

Gross Margin

71.98%

+1.0%

Market Cap

€978.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.33

N/A

Employees

957

N/A

Net Income

€6.93

-0.5%

EBITDA

€11.56

-0.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€161.39

-8.8%

Total Debt

€31.44

+0.9%

Accounts Receivable

€86.13

+2.9%

Inventory

€40.97

+0.9%

Long Term Debt

€26.03

+0.9%

Short Term Debt

€5.40

+1.2%

Return on Assets

82.48%

-0.0%

Return on Invested Capital

-43.75%

-0.1%

Free Cash Flow

€16.39

-0.7%

Operating Cash Flow

€16.82

-0.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About SR3

What is the current price of STAAR Surgical?

STAAR Surgical is trading at €18.99 per share.

What is the 52-week range for STAAR Surgical?

Over the past 52 weeks, STAAR Surgical has traded between €13.51 and €29.00.

How much debt does STAAR Surgical have?

As of the most recent reporting period, STAAR Surgical reported total debt of €31.44M.

How much cash does STAAR Surgical have on hand?

STAAR Surgical reported €129.96M in cash and cash equivalents in its most recent financial results.

What is STAAR Surgical’s dividend yield?

STAAR Surgical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.